Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion

Quan-tai Xing; Chun-mei Qu; Gang Wang
May 2014
OncoTargets & Therapy;2014, Vol. 7, p881
Academic Journal
Introduction: Abl2 nonreceptor tyrosine kinase (Arg, c-abl oncogene 2) has recently been identified as being recurrently amplified at DNA levels and overexpressed at mRNA levels in hepatocellular carcinomas (HCCs), and might be a potential oncogenic driver and therapeutic target for HCC. Methods: In this study, we investigated the Abl2 expression in a series of HCC tumors by immunohistochemistry and further evaluated its clinicopathological and prognostic significance. We also performed an in vitro experiment to validate the effect of Abl2 gene silencing on the migration and invasion abilities of human liver cancer HepG2 cells. Results: It has been demonstrated that Abl2 was unregulated in 37.3% (28/75) of primary HCC tissues, and was significantly associated with a shorter overall survival time (P=0.0005). In addition, Abl2 gene silencing in HepG2 cells significantly attenuated its migration and invasion abilities in vitro. We also found that the phosphorylation of metastasis-associated gene cortactin was markedly decreased by Abl2 silencing. Conclusion: We propose that Abl2 might be a potential candidate therapeutic target for HCCs and that targeted therapies against Abl2 in the treatment of HCCs deserve further investigation in the future.


Related Articles

  • 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma. Chia-Chia Liu; Yee-Jee Jan; Bor-Sheng Ko; Yao-Ming Wu; Shu-Man Liang; Shyh-Chang Chen; Yen-Ming Lee; Tzu-An Liu; Tzu-Ching Chang; Wang, John; Song-Kun Shyue; Li-Ying Sung; Jun-Yang Liou // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background 14-3-3σ is implicated in promoting tumor development of various malignancies. However, the clinical relevance of 14-3-3σ in hepatocellular carcinoma (HCC) tumor progression and modulation and pathway elucidation remain unclear. Methods We investigated 14-3-3σ expression in...

  • RANKL Promotes Migration and Invasion of Hepatocellular Carcinoma Cells via NF-κB-Mediated Epithelial-Mesenchymal Transition. Song, Fang-Nan; Duan, Meng; Liu, Long-Zi; Wang, Zhi-Chao; Shi, Jie-Yi; Yang, Liu-Xiao; Zhou, Jian; Fan, Jia; Gao, Qiang; Wang, Xiao-Ying // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background: Metastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown. Methods: Immunohistochemistry was performed to...

  • Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing. Sheng Gao; Zhe Yang; Zheng, Zhi-Yun; Jia Yao; Feng Zhang; Wu, Li-Ming; Xie, Hai-Yang; Lin zhou; Zheng, Shu-Sen // World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, p1 

    Background: Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies in humans, and its prognosis is generally poor even after surgery. Many advances have been made to understand the pathogenesis of HCC; however, the molecular mechanisms that lead to hepatocarcinogenesis and...

  • Deregulation between miR-29b/c and DNMT3A Is Associated with Epigenetic Silencing of the CDH1 Gene, Affecting Cell Migration and Invasion in Gastric Cancer. Cui, He; Wang, Ling; Gong, Pihai; Zhao, Chengcheng; Zhang, Shaodan; Zhang, Kun; Zhou, Rongping; Zhao, Zhujiang; Fan, Hong // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    The de-regulation of the miR-29 family and DNA methyltransferase 3A (DNMT3A) is associated with gastric cancer (GC). While increasing evidence indicates miR-29b/c could regulate DNA methylation by targeting DNMT3A, it is currently unknown if epigenetic silencing of miR-29b/c via promoter...

  • BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer. Bai, Jin; Mei, Pengjin; Zhang, Cuipeng; Chen, Feifei; Li, Chen; Pan, Zhenqiang; Liu, Hui; Zheng, Junnian // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    BRG1, a core component of the SWI/SNF chromatin-remodeling complex, has been implicated in cancer development; however, the biological significance of BRG1 in breast cancer remains unknown. We explored the role of BRG1 in human breast cancer pathogenesis. Using tissue microarray and...

  • Promoting Colonization in Metastatic HCC Cells by Modulation of Autophagy. Peng, Yuan-Fei; Shi, Ying-Hong; Shen, Ying-Hao; Ding, Zhen-Bin; Ke, Ai-Wu; Zhou, Jian; Qiu, Shuang-Jian; Fan, Jia // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Background:Autophagy is an important adaptive survival mechanism, which has been postulated to be involved in cancer metastasis. The purpose of this study was to investigate autophagy in metastasis of hepatocellular carcinoma (HCC). Methods:Immunohistochemical analysis of autophagic...

  • Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma. Yang, Li-Hua; Wang, Ye; Qiao, Shi; Wang, Min-Jun; Chen, Fei; Zi, Xiao-Yuan; Li, Jian-Xiu; Zhang, Hai-Bin; Yu, Bing; Hu, Yi-Ping // Cancer Management & Research;Apr2018, Vol. 10, p873 

    Purpose: Liver cancer stem cells (CSCs) are known to be associated with the development, survival, proliferation, metastasis, and recurrence of liver tumors. The aim of this study was to investigate the association of liver-enriched activator protein 1 (LAP1) with hepatocellular carcinoma (HCC)...

  • High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma. Zhang, Yi-An; Zhu, Ji-Min; Yin, Jie; Tang, Wen-Qing; Guo, Yan-Mei; Shen, Xi-Zhong; Liu, Tao-Tao // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Neuro-oncological ventral antigen 1 (Nova1) is a neuron-specific RNA-binding protein in human paraneoplastic opsoclonus-myoclonus ataxia accompanying with malignant tumors, but its role in hepatocellular carcinoma (HCC) remains elusive. In this study, we found that overexpressed intratumoral...

  • BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma. Guozhi Yin; Zhikui Liu; Yufeng Wang; Changwei Dou; Chao Li; Wei Yang; Yingmin Yao; Qingguang Liu; Kangsheng Tu; Yin, Guozhi; Liu, Zhikui; Wang, Yufeng; Dou, Changwei; Li, Chao; Yang, Wei; Yao, Yingmin; Liu, Qingguang; Tu, Kangsheng // BMC Cancer;2/15/2016, Vol. 16, p1 

    Background: The deregulation of E-cadherin has been considered as a leading cause of hepatocellular carcinoma (HCC) metastasis. BCL6 corepressor-like 1 (BCORL1) is a transcriptional corepressor and contributes to the repression of E-cadherin. However, the clinical significance of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics